Literature DB >> 15031036

Selenoprotein synthesis and side-effects of statins.

Bernd Moosmann1, Christian Behl.   

Abstract

Statins are possibly the most effective drugs for the prevention and treatment of hypercholesterolaemia and coronary heart disease. They are generally well tolerated, however, they do cause some unusual side-effects with potentially severe consequences, most prominently myopathy or rhabdomyolysis and polyneuropathy. We noted that the pattern of side-effects associated with statins resembles the pathology of selenium deficiency, and postulated that the mechanism lay in a well established, but often overlooked, biochemical pathway--the isopentenylation of selenocysteine-tRNA([Ser]Sec). A negative effect of statins on selenoprotein synthesis does seem to explain many of the enigmatic effects and side-effects of statins, in particular, statin-induced myopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031036     DOI: 10.1016/S0140-6736(04)15739-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

1.  Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle.

Authors:  Annette Draeger; Verónica Sanchez-Freire; Katia Monastyrskaya; Hans Hoppeler; Matthias Mueller; Fabio Breil; Markus G Mohaupt; Eduard B Babiychuk
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 2.  Mechanisms and assessment of statin-related muscular adverse effects.

Authors:  Dirk Moßhammer; Elke Schaeffeler; Matthias Schwab; Klaus Mörike
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

3.  Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice.

Authors:  Ilayaraja Muthuramu; Ruhul Amin; Andrey Postnov; Mudit Mishra; Joseph Pierre Aboumsallem; Tom Dresselaers; Uwe Himmelreich; Paul P Van Veldhoven; Olivier Gheysens; Frank Jacobs; Bart De Geest
Journal:  Mol Ther       Date:  2017-08-01       Impact factor: 11.454

4.  Underappreciated statin-induced myopathic weakness causes disability.

Authors:  Bruce H Dobkin
Journal:  Neurorehabil Neural Repair       Date:  2005-09       Impact factor: 3.919

Review 5.  Advances in understanding drug-induced neuropathies.

Authors:  Amanda C Peltier; James W Russell
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  Higher selenium status is associated with adverse blood lipid profile in British adults.

Authors:  Saverio Stranges; Martin Laclaustra; Chen Ji; Francesco P Cappuccio; Ana Navas-Acien; Jose M Ordovas; Margaret Rayman; Eliseo Guallar
Journal:  J Nutr       Date:  2009-11-11       Impact factor: 4.798

Review 7.  Understanding the importance of selenium and selenoproteins in muscle function.

Authors:  M Rederstorff; A Krol; A Lescure
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

8.  Simvastatin activates Keap1/Nrf2 signaling in rat liver.

Authors:  Ioannis G Habeos; Panos G Ziros; Dionysios Chartoumpekis; Agathoklis Psyrogiannis; Venetsana Kyriazopoulou; Athanasios G Papavassiliou
Journal:  J Mol Med (Berl)       Date:  2008-09-02       Impact factor: 4.599

Review 9.  The role of statin therapy in the management of cardiomyopathies.

Authors:  Kumudha Ramasubbu; John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2009-03       Impact factor: 5.113

10.  Impact of adherence to statins on chronic heart failure in primary prevention.

Authors:  Sylvie Perreault; Alice Dragomir; Lucie Blais; Anick Bérard; Lyne Lalonde; Michel White
Journal:  Br J Clin Pharmacol       Date:  2008-07-24       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.